61 results
CORRESP
FGEN
FibroGen Inc
16 Dec 21
Correspondence with SEC
12:00am
and therapies as us, China’s government may in the future take regulatory actions that materially adversely affect the business environment and financial markets … and therapies as us, China’s government may in the future take regulatory actions that materially adversely affect the business environment and financial
8-K
EX-99.1
FGEN
FibroGen Inc
26 Sep 19
FibroGen Announces Initiation of Phase 2 Clinical Trial of Roxadustat for the Treatment
9:01am
, it is often not recognized and is frequently undertreated. CIA can adversely affect long-term patient outcomes, as the anemic environment may limit
8-K
EX-99.1
FGEN
FibroGen Inc
8 Jun 18
Regulation FD Disclosure
5:27pm
work and roxa does work without modification or increased dose. So in that kind of environment if the results bear out, they’re willing to talk to us
CORRESP
FGEN
FibroGen Inc
23 Oct 14
Correspondence with SEC
12:00am
reflects a remarkable improvement in the relevant market environment since September 26, 2013. This improvement is evidenced by, among other things, the more